Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Lrig1 could be a marker for advanced sebaceous carcinoma.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Upadacitinib effectively treats pyoderma gangrenosum.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

EGF receptors are crucial for skin cell growth and decrease with age.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

A new drug strategy improves hair loss treatment with better results and safety.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.

PAD type III enzyme is specific to rat skin and hair follicles.

Retinoic acid helps change skin cells and is important for skin development and hair growth.

The enzymes Aldh1a2 and Aldh1a3 are involved in making retinoic acid in hair follicles and have different roles in hair growth.